AVITA Medical (AVHHL) Total Non-Current Liabilities (2018 - 2025)
AVITA Medical (AVHHL) reported Total Non-Current Liabilities of $71.8 million for Q4 2025, little changed on a YoY basis from $71.5 million in Q4 2024, and up 4.76% quarter-over-quarter from $68.5 million in Q3 2025.
AVITA Medical (AVHHL) Total Non-Current Liabilities (2018 - 2025) Analysis & Trends
AVITA Medical has reported Total Non-Current Liabilities for 8 years, with the latest figure at $71.8 million in Q4 2025.
- For the quarter ending Q4 2025, Total Non-Current Liabilities changed 0.37% year-over-year to $71.8 million; the trailing twelve-month figure through Dec 2025 stood at $71.8 million (changed 0.37% YoY), and the FY2025 full-year result was $71.8 million, changed 0.37% from the prior year.
- Total Non-Current Liabilities for Q4 2025 stood at $71.8 million, up from $68.5 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $71.8 million in Q4 2025, with the low at $8.1 million in Q1 2022.
- Historically, Total Non-Current Liabilities has averaged $41.6 million across 5 years, with a median of $59.3 million in 2023.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities slipped 11.18% — and 2023, when it jumped 405.49%.
- AVITA Medical's Total Non-Current Liabilities stood at $11.3 million in 2021, then increased by 3.02% to $11.6 million in 2022, then jumped by 405.49% to $58.7 million in 2023, then rose by 21.8% to $71.5 million in 2024, then gained by 0.37% to $71.8 million in 2025.
- The last three Total Non-Current Liabilities figures came in at $71.8 million (Q4 2025), $68.5 million (Q3 2025), and $69.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 3.47 Bn |
| 10 | AVITA Medical | - | - | 14.31 Mn | 71.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 71.80 Mn |
| Sep 30, 2025 | 68.53 Mn |
| Jun 30, 2025 | 69.08 Mn |
| Mar 31, 2025 | 71.01 Mn |
| Dec 31, 2024 | 71.54 Mn |
| Sep 30, 2024 | 65.84 Mn |
| Jun 30, 2024 | 61.55 Mn |
| Mar 31, 2024 | 59.96 Mn |
| Dec 31, 2023 | 58.73 Mn |
| Dec 31, 2022 | 11.62 Mn |
| Jun 30, 2022 | 9.23 Mn |
| Mar 31, 2022 | 8.11 Mn |
| Dec 31, 2021 | 11.28 Mn |
| Sep 30, 2021 | 9.18 Mn |
| Jun 30, 2021 | 9.34 Mn |
| Mar 31, 2021 | 9.13 Mn |
| Jun 30, 2020 | 10.06 Mn |
| Jun 30, 2019 | 465,625.64 |
| Jun 30, 2018 | 101,698.83 |